NEWS
Our Latest News
ARCHIMED acquires generative AI Diagnostics player Arkstone to support fight against infectious disease
Private equity healthcare specialist ARCHIMED acquired a majority stake in Arkstone Medical Solutions (Arkstone), a pioneer in infectious disease clinical guidance and antimicrobial stewardship based on machine learning (ML) and generative artificial intelligence (gen AI).
Partnering with existing owners and management, ARCHIMED acquires majority interest in NAMSA, the world leader in medical device testing
September
1,
2020
ARCHIMED raises €1 billion for its MED Platform I Fund
August
28,
2020
ARCHIMED acquires ActiGraph, the fast-growing leader in remote monitoring of mobility and sleep for drug trials
May
18,
2020
368